NASDAQ:ICCC - ImmuCell Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$7.20 -0.05 (-0.69 %)
(As of 01/17/2019 08:35 AM ET)
Previous Close$7.25
Today's Range$7.0089 - $7.24
52-Week Range$6.38 - $9.30
Volume2,347 shs
Average Volume2,355 shs
Market Capitalization$39.77 million
P/E RatioN/A
Dividend YieldN/A
Beta1.24
ImmuCell Corporation, an animal health company, develops, acquires, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company primarily offers First Defense, an orally delivered scours preventive product for newborn calves. It also provides California Mastitis Test, which is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic. In addition, the company is involved in developing purified Nisin treatment for subclinical mastitis in lactating dairy cows; and selling various product applications of its First Defense Technology, including a whey protein concentrate for the nutritional and feed supplement markets. ImmuCell Corporation sells its products to animal health distributors, fleet stores, and direct to farms. The company was founded in 1982 and is headquartered in Portland, Maine.

Receive ICCC News and Ratings via Email

Sign-up to receive the latest news and ratings for ICCC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ICCC
CUSIPN/A
Phone207-878-2770

Debt

Current Ratio3.23
Quick Ratio2.07

Price-To-Earnings

Sales & Book Value

Annual Sales$10.43 million
Price / Sales3.79
Cash Flow$0.1327 per share
Price / Cash Flow54.24
Book Value$4.31 per share
Price / Book1.67

Profitability

Net Income$-160,000.00
Net Margins-13.09%
Return on Assets-2.69%

Miscellaneous

Employees47
Market Cap$39.77 million
OptionableNot Optionable

ImmuCell (NASDAQ:ICCC) Frequently Asked Questions

What is ImmuCell's stock symbol?

ImmuCell trades on the NASDAQ under the ticker symbol "ICCC."

How were ImmuCell's earnings last quarter?

ImmuCell Co. (NASDAQ:ICCC) posted its quarterly earnings results on Tuesday, November, 13th. The biotechnology company reported ($0.05) EPS for the quarter. The biotechnology company earned $2.15 million during the quarter. ImmuCell had a negative net margin of 13.09% and a negative return on equity of 3.89%. View ImmuCell's Earnings History.

When is ImmuCell's next earnings date?

ImmuCell is scheduled to release their next quarterly earnings announcement on Thursday, February 14th 2019. View Earnings Estimates for ImmuCell.

Has ImmuCell been receiving favorable news coverage?

Press coverage about ICCC stock has been trending somewhat positive this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. ImmuCell earned a media sentiment score of 1.5 on InfoTrie's scale. They also gave press coverage about the biotechnology company a news buzz of 7.0 out of 10, indicating that recent news coverage is likely to have an effect on the stock's share price in the near future.

Who are some of ImmuCell's key competitors?

Who are ImmuCell's key executives?

ImmuCell's management team includes the folowing people:
  • Mr. Michael F. Brigham, Pres, CEO, Treasurer, Sec. & Director (Age 57)
  • Dr. Joseph H. Crabb, VP & Chief Scientific Officer (Age 63)
  • Ms. Bobbi Jo Brockmann, VP of Sales & Marketing and Director (Age 41)
  • Ms. Elizabeth L. Williams, VP of Manufacturing Operations (Age 62)
  • Mr. A. Gustavo Scaffa, Sr. Director of Quality

How do I buy shares of ImmuCell?

Shares of ICCC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ImmuCell's stock price today?

One share of ICCC stock can currently be purchased for approximately $7.20.

How big of a company is ImmuCell?

ImmuCell has a market capitalization of $39.77 million and generates $10.43 million in revenue each year. ImmuCell employs 47 workers across the globe.

What is ImmuCell's official website?

The official website for ImmuCell is http://www.immucell.com.

How can I contact ImmuCell?

ImmuCell's mailing address is 56 EVERGREEN DR, PORTLAND ME, 04103. The biotechnology company can be reached via phone at 207-878-2770 or via email at [email protected]


MarketBeat Community Rating for ImmuCell (NASDAQ ICCC)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  95 (Vote Outperform)
Underperform Votes:  64 (Vote Underperform)
Total Votes:  159
MarketBeat's community ratings are surveys of what our community members think about ImmuCell and other stocks. Vote "Outperform" if you believe ICCC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ICCC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel